Skip to content

Evaluation of anesthesia in cardiac surgery patients

Evaluation of the analgesic efficacy of general and spinal anesthesia with morphine associated ropivacaine in patients who underwent surgery type coronary artery bypass grafting

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8m444q
Enrollment
Unknown
Registered
2012-03-09
Start date
2012-03-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic ischemic heart disease, unspecified

Interventions

In the experimental group, composed of 30 subjects, subarachnoid puncture is performed with patient in sitting position, after infiltration before skin and subcutaneous tissue with lidocaine 2% withou
second injection of 0.6 ml ropivacaine, 0.5% hyperbaric with 3ml doubly distilled water. After 15 minutes, it will elevate the lower limbs. Then begins the induction of general anesthesia with Dipriva
drug
procedure/surgery

Sponsors

Universidade Federal do Rio Grande do Norte
Lead Sponsor
Promater Hospital Geral
Collaborator

Eligibility

Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Assessment of the physical status; Anesthetic risk classification according to the American Society of Anesthesiologists (ASA) ASA II and III; The indication of coronary artery bypass grafting; Verbal skills and understanding appropriate to participate in the interview; - No pain preoperatively.

Exclusion criteria

Exclusion criteria: Manifestation of the patient and / or guardian's desire not to continue in the study; Present severe postoperative complications such as respiratory and heart failure, valvular heart disease associated procedures and emergencies, reoperation; Other disorders pre-operative treatment with heparin, since it may affect patients' responses to questions about pain.

Design outcomes

Secondary

MeasureTime frame
Reduced time to wake analyzed by checking the record time in the patient. Increased time for the request of analgesic analyzed by checking the record time in the patient. Absence or diminution of thoracic drains analyzed by visualization after the intervention. Absence or reduction of hyperemia before removal of drains by viewing the time of chest removal of the drain. Reduction of pain intensity in the removal of drains, measured by visual analog scale. Decrease in analgesic consumption measured by the amount of drugs consumed by the patient

Primary

MeasureTime frame
Improvement of the pain intensity, measured by the visual analogue scale (VAS), with scores ranging from 0 to 10 where 0 indicates no pain and 10 to give maximum.;Improves the quality of painmeasured by the McGill pain scale that assesses the painful experience in the dimensions: sensory, affective and evaluative and is based on words that patients select to describe their pain. Reduction of the location of pain, measured by direct question to the respondent.

Countries

Brazil

Contacts

Public ContactValdecy Pinheiro

Universidade Federal do Rio Grande do Norte

valdecy63@gmail.com84 99939807

Outcome results

None listed

Source: REBEC (via WHO ICTRP)